STATUS: EDITORIAL / NOT A LAW FIRM / NOT A CLINIC
About this reading room
Independent editorial summaries of the KLOW regulatory record, source-linked to PubMed, FDA notices, WADA listings, and court filings.
What this site is
Legal KLOW is an independent editorial project that publishes summaries of the peer-reviewed research literature and the public regulatory record on the KLOW research peptide blend (GHK-Cu + BPC-157 + TB-500 + KPV). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We are not a law firm. We do not employ lawyers and we do not provide legal advice. We do not manufacture, sell, distribute, import, or compound any product. Our work is editorial commentary on publicly available science and on publicly available regulatory action.
Why 'Legal KLOW'
The modifier 'legal' in the site name is editorial framing — a position the publisher occupies relative to the literature, not a claim about the site's services. The regulatory record on the four KLOW components is unusually dense for a research peptide blend: an FDA Category 2 placement in September 2023, ongoing Evexias/Farmakeio litigation challenging the procedural basis of that placement, a Department of Justice prosecution of Tailor Made Compounding involving a guilty plea, a WADA S0 listing of BPC-157, separate USADA and OPSS athlete advisories, and a quietly persistent question about whether 'not a controlled substance' implies anything else at all. Reading that record requires sitting with primary sources. This site exists to make that reading easier. It does not exist to interpret the record on any specific reader's behalf.
How the site is sourced
Every quantitative claim on the site cites a primary source. Eighteen peer-reviewed studies anchor the mechanism and research-record pages. Regulatory claims cite the relevant FDA publication, WADA Prohibited List entry, USADA advisory, OPSS bulletin, or court filing. The /references page lists every primary source with DOI and PubMed/PMC links. Where the record is uncertain — for example the unpublished Pliva PL 14736 Phase 2 trial, or the limited published PK data on the TB-500 fragment — the uncertainty is stated, not papered over.
Editorial standards
The site avoids prescriptive language. It describes what the published literature reports and what the regulatory record says. It does not recommend doses, routes, sources, or use cases. It does not name commercial vendors. It does not interlink with any other site in the publisher's portfolio. It does not give legal advice on any specific situation. Where the literature is preclinical-dominated — which is the case for all four KLOW components — the preclinical character of the evidence is stated explicitly. The 2025 HSS Journal systematic review's conclusion that the human evidence base is insufficient to support clinical recommendation is the editorial benchmark for how the research is framed on this site.
What we will and will not change
Source-linked corrections are read first and acted on. If a citation is wrong, a study has been retracted, or a regulatory publication has been superseded, please send the DOI or PubMed ID of the corrected source through the contact page. Editorial framing — the choice to position the site as a regulatory reading room rather than a legal-advice or medical-advice resource — is the publisher's call and will not change in response to reader requests. The choice not to name commercial vendors will not change. The choice not to interlink with other sites in the publisher's portfolio will not change. The footer disclaimer will not change.
Footer disclaimer
Legal KLOW is an independent editorial reading room publishing source-linked summaries of the public regulatory and research record on the KLOW four-peptide blend. It is not a law firm and does not provide legal advice on any specific situation. It is not a clinical practice and does not provide medical advice. It does not manufacture, sell, distribute, import, or compound any product. Every claim is attributed to a primary source; the references are available on the /references page.